P59: omalizumab to treat idiopathic non ‐histaminergic acquired angioedema

Internal Medicine Journal,Volume 48, Issue S6, Page 22-22, November 2018.
Source: Internal Medicine Journal - Category: Internal Medicine Source Type: research